Robert E. Ward

Robert E. Ward

Direktor/Vorstandsmitglied bei
Massachusetts High Technology Council, Inc.
68 Jahre
Health Technology
Consumer Services
Transportation

Profil

Robert E.
Ward
currently works at Massachusetts High Technology Council, Inc., as Director and Antidote Therapeutics, Inc., as Director.
Mr. Ward also formerly worked at Radius Health, Inc., as President, Chief Executive Officer & Director from 2013 to 2017, Eloxx Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2017 to 2020, OncoSec Medical, Inc., as Independent Director from 2018 to 2021, Clarkson Plc, as Finance Director, Akari Therapeutics Plc, as Independent Director from 2016 to 2018, Harriman Biopartners LLC, as Managing Director from 2010 to 2011, AstraZeneca PLC, as Vice President-Strategy & External Alliances from 2011 to 2013, and NPS Pharmaceuticals, Inc., as Vice President-Corporate Development from 2006 to 2010.
Mr. Ward received his undergraduate degree from the University of California, Santa Barbara, graduate degree from New Jersey Institute of Technology, and graduate degree from The Johns Hopkins University School of Medicine.

Aktive Positionen von Robert E. Ward

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Robert E. Ward

UnternehmenPositionEnde
ONCOSEC MEDICAL INCORPORATED Direktor/Vorstandsmitglied 23.11.2021
ELOXX PHARMACEUTICALS, INC. Vorstandsvorsitzender 29.02.2020
AKARI THERAPEUTICS, PLC Direktor/Vorstandsmitglied 01.08.2018
RADIUS HEALTH, INC. Vorstandsvorsitzender 17.07.2017
ASTRAZENECA PLC Corporate Officer/Principal 01.12.2013
Sehen Sie sich die Erfahrung von Robert E. Ward im Detail an

Ausbildung von Robert E. Ward

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

65

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen13

Health Technology

Health Technology

Health Technology

Health Technology

Transportation

Consumer Services

Consumer Services

Technology Services

Consumer Services

Health Technology

Harriman Biopartners LLC

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Robert E. Ward
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT